Malaria Programme

Why it matters

There were about 282 million malaria cases and 610,000 deaths globally in 2024, and the burden is overwhelmingly concentrated: the WHO African Region had 95% of cases and 95% of deaths, with children under five making up around 76% of deaths in the Region (WHO, 2025). Resources fall well short of the need — 2023 malaria funding was about $4 billion against an $8.3 billion target, leaving gaps in nets, medicines, and other tools (WHO, 2024). Proven tools can change the trajectory: roughly 1 in 8 child deaths were averted among children eligible for the RTS,S vaccine in Ghana, Kenya, and Malawi, and WHO expects tens of thousands of lives could be saved each year with wider rollout (WHO, 2026).

InBasket AI keeps each malaria case on one continuous record so a small care team can work from a single, trustworthy source of truth — part of expanding access to care for the next billion people.

Designed with reference to recognized global, national, and clinical standards

This care area is designed with reference to a standards ecosystem, including global guidance, national protocols, specialty-society recommendations, interoperability standards, and programme reporting requirements where applicable:

• WHO Guidelines for malaria (test, treat, track)
• WHO guidance on management of severe malaria (referral)
• RBM Partnership / Global Fund malaria programme indicators where adopted
• National malaria diagnosis, treatment, stock, surveillance, and case-reporting requirements
• National Ministry of Health standard treatment guidelines, essential medicines lists, and local scope-of-practice rules for the implementation setting
• HL7 FHIR, ICD-10, LOINC, SNOMED CT, and local terminology/coding standards where adopted
• National programme registers, surveillance definitions, DHIS2 or equivalent reporting requirements, and donor-reporting mappings where adopted

Standards sources

These sources substantiate the standards named above. Implementation-specific national protocols are selected from official national or regional authorities during deployment.

1. [1]World Health Organization guidelines and publications
2. [2]The Global Fund
3. [3]RBM Partnership to End Malaria
4. [4]Official national Ministry of Health protocols for the implementation setting — Implementation-specific: selected from the official national or regional authority during deployment.
5. [5]HL7 FHIR
6. [6]WHO ICD classifications
7. [7]LOINC
8. [8]SNOMED CT
9. [9]National programme registers, DHIS2 or equivalent reporting requirements — Implementation-specific programme registers and reporting rules are configured from official national systems where adopted.

Evidence sources

• WHO Malaria (2025)
• ·WHO World Malaria Report 2024
• ·WHO Malaria vaccine evidence (2026)